Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 pseudogene 1 (MTHFD1P1) is classified as a pseudogene, meaning it is a segment of DNA that shares sequence similarity with the protein-coding MTHFD1 gene but does not encode a functional protein. It retains homology with the functional gene involved in folate metabolism and one-carbon metabolism, but there is no evidence it acts as a drug target, encodes an active enzyme, or has a defined biological or therapeutic function in humans[5]. Notes: - MTHFD1P1 is a pseudogene and not a functional gene or protein; thus, it is not an enzyme, receptor, transporter, or therapeutic target[5]. - No evidence supports its use in disease, drug targeting, or biomarker development. - Many of the alternate names refer to the *functional* gene or its activities, not to the pseudogene itself. - This entry is considered "incorrect" as a drug target due to its pseudogene status and lack of functional or clinical relevance[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 pseudogene 1 (MTHFD1P1).